Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Plasma cell 1Gastrointestinal 1

Conditions

Rectal Neoplasms 1Pancreatic Neoplasms 1Multiple Myeloma 1Liver Neoplasms 1Glioblastoma 1Gallbladder Neoplasms 1Colonic Neoplasms 1

Interventions

Oxaliplatin 2Leucovorin 2Gemcitabine 2Fluorouracil 2Bevacizumab 2Azacitidine 2temsirolimus 1ruxolitinib 1rucaparib 1repotrectinib 1fludarabine 1ceritinib 1cc-486 1abiraterone 1Uncertainty 1Thalidomide 1Temozolomide 1Suspensions 1Sorafenib 1Quality of Life 1Psychosocial Intervention 1Patient Reported Outcome Measures 1Paclitaxel 1Molecular Diagnostic Techniques 1Lenalidomide 1Irinotecan 1Interleukin-2 1Injections 1Immunotherapy 1INCB057643 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioblastoma × Cannabidiol × Plasma cell × Clear all
NCT03607643 2018-07-31

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Leaf Vertical Inc.

Phase 1/2 Unknown
160 enrolled
CNSGastrointestinalPlasma cell

Colonic Neoplasms, Gallbladder Neoplasms, Glioblastoma, Liver Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡